- Home
- WCT vs TELA Comparison
WCT vs TELA Comparison
Compare WCT & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WCT
- TELA
- Stock Information
- Founded
- WCT 2012
- TELA 2012
- Country
- WCT Hong Kong
- TELA United States
- Employees
- WCT N/A
- TELA N/A
- Industry
- WCT
- TELA Medical/Dental Instruments
- Sector
- WCT
- TELA Health Care
- Exchange
- WCT NYSE
- TELA Nasdaq
- Market Cap
- WCT 74.2M
- TELA 61.8M
- IPO Year
- WCT 2024
- TELA 2019
- Fundamental
- Price
- WCT $1.07
- TELA $2.93
- Analyst Decision
- WCT
- TELA Strong Buy
- Analyst Count
- WCT 0
- TELA 4
- Target Price
- WCT N/A
- TELA $9.25
- AVG Volume (30 Days)
- WCT 2.4M
- TELA 132.9K
- Earning Date
- WCT 12-24-2024
- TELA 11-07-2024
- Dividend Yield
- WCT N/A
- TELA N/A
- EPS Growth
- WCT 20.11
- TELA N/A
- EPS
- WCT 0.05
- TELA N/A
- Revenue
- WCT $2,489,995.00
- TELA $68,649,000.00
- Revenue This Year
- WCT N/A
- TELA $30.39
- Revenue Next Year
- WCT N/A
- TELA $25.51
- P/E Ratio
- WCT $23.68
- TELA N/A
- Revenue Growth
- WCT 49.00
- TELA 29.34
- 52 Week Low
- WCT $0.94
- TELA $2.30
- 52 Week High
- WCT $9.36
- TELA $7.84
- Technical
- Relative Strength Index (RSI)
- WCT N/A
- TELA 47.50
- Support Level
- WCT N/A
- TELA $2.69
- Resistance Level
- WCT N/A
- TELA $3.09
- Average True Range (ATR)
- WCT 0.00
- TELA 0.18
- MACD
- WCT 0.00
- TELA -0.03
- Stochastic Oscillator
- WCT 0.00
- TELA 30.77
About WCT WELLCHANGE HOLDINGS COMPANY LIMITED
Wellchange Holdings Co Ltd is an enterprise software solution services provider. It provides software solutions, cloud-based software-as-a-service ("SaaS") platforms, and "white-label" software design and development services.
About TELA TELA Bio Inc.
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.